[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global POCT Molecular Diagnostics Technology Supply, Demand and Key Producers, 2023-2029

June 2023 | 106 pages | ID: G0C2D9C46C35EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global POCT Molecular Diagnostics Technology market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global POCT Molecular Diagnostics Technology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for POCT Molecular Diagnostics Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of POCT Molecular Diagnostics Technology that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global POCT Molecular Diagnostics Technology total market, 2018-2029, (USD Million)

Global POCT Molecular Diagnostics Technology total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: POCT Molecular Diagnostics Technology total market, key domestic companies and share, (USD Million)

Global POCT Molecular Diagnostics Technology revenue by player and market share 2018-2023, (USD Million)

Global POCT Molecular Diagnostics Technology total market by Type, CAGR, 2018-2029, (USD Million)

Global POCT Molecular Diagnostics Technology total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global POCT Molecular Diagnostics Technology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ustar Biotechnologies (Hangzhou) Ltd., Cepheid, Abbott Laboratories, Roche Holding AG, BioFire Diagnostics, Beijing Bohui Innovat Biotech Grp Co Ltd., CapitalBio Corporation, Daan Gene and Sansure Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World POCT Molecular Diagnostics Technology market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global POCT Molecular Diagnostics Technology Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global POCT Molecular Diagnostics Technology Market, Segmentation by Type
  • Molecular Point-of-Care Diagnostics
  • Near-Patient Molecular
Global POCT Molecular Diagnostics Technology Market, Segmentation by Application
  • Microbiology Laboratory
  • Hospital
  • Clinic
Companies Profiled:
  • Ustar Biotechnologies (Hangzhou) Ltd.
  • Cepheid
  • Abbott Laboratories
  • Roche Holding AG
  • BioFire Diagnostics
  • Beijing Bohui Innovat Biotech Grp Co Ltd.
  • CapitalBio Corporation
  • Daan Gene
  • Sansure Biotech
  • Coyote Bioscience Co., Ltd.
  • Genmark Diagnostics, Inc.
  • Mobidiag
  • Wondfo
Key Questions Answered

1. How big is the global POCT Molecular Diagnostics Technology market?

2. What is the demand of the global POCT Molecular Diagnostics Technology market?

3. What is the year over year growth of the global POCT Molecular Diagnostics Technology market?

4. What is the total value of the global POCT Molecular Diagnostics Technology market?

5. Who are the major players in the global POCT Molecular Diagnostics Technology market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 POCT Molecular Diagnostics Technology Introduction
1.2 World POCT Molecular Diagnostics Technology Market Size & Forecast (2018 & 2022 & 2029)
1.3 World POCT Molecular Diagnostics Technology Total Market by Region (by Headquarter Location)
  1.3.1 World POCT Molecular Diagnostics Technology Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States POCT Molecular Diagnostics Technology Market Size (2018-2029)
  1.3.3 China POCT Molecular Diagnostics Technology Market Size (2018-2029)
  1.3.4 Europe POCT Molecular Diagnostics Technology Market Size (2018-2029)
  1.3.5 Japan POCT Molecular Diagnostics Technology Market Size (2018-2029)
  1.3.6 South Korea POCT Molecular Diagnostics Technology Market Size (2018-2029)
  1.3.7 ASEAN POCT Molecular Diagnostics Technology Market Size (2018-2029)
  1.3.8 India POCT Molecular Diagnostics Technology Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 POCT Molecular Diagnostics Technology Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 POCT Molecular Diagnostics Technology Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World POCT Molecular Diagnostics Technology Consumption Value (2018-2029)
2.2 World POCT Molecular Diagnostics Technology Consumption Value by Region
  2.2.1 World POCT Molecular Diagnostics Technology Consumption Value by Region (2018-2023)
  2.2.2 World POCT Molecular Diagnostics Technology Consumption Value Forecast by Region (2024-2029)
2.3 United States POCT Molecular Diagnostics Technology Consumption Value (2018-2029)
2.4 China POCT Molecular Diagnostics Technology Consumption Value (2018-2029)
2.5 Europe POCT Molecular Diagnostics Technology Consumption Value (2018-2029)
2.6 Japan POCT Molecular Diagnostics Technology Consumption Value (2018-2029)
2.7 South Korea POCT Molecular Diagnostics Technology Consumption Value (2018-2029)
2.8 ASEAN POCT Molecular Diagnostics Technology Consumption Value (2018-2029)
2.9 India POCT Molecular Diagnostics Technology Consumption Value (2018-2029)

3 WORLD POCT MOLECULAR DIAGNOSTICS TECHNOLOGY COMPANIES COMPETITIVE ANALYSIS

3.1 World POCT Molecular Diagnostics Technology Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global POCT Molecular Diagnostics Technology Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for POCT Molecular Diagnostics Technology in 2022
  3.2.3 Global Concentration Ratios (CR8) for POCT Molecular Diagnostics Technology in 2022
3.3 POCT Molecular Diagnostics Technology Company Evaluation Quadrant
3.4 POCT Molecular Diagnostics Technology Market: Overall Company Footprint Analysis
  3.4.1 POCT Molecular Diagnostics Technology Market: Region Footprint
  3.4.2 POCT Molecular Diagnostics Technology Market: Company Product Type Footprint
  3.4.3 POCT Molecular Diagnostics Technology Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: POCT Molecular Diagnostics Technology Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: POCT Molecular Diagnostics Technology Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: POCT Molecular Diagnostics Technology Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: POCT Molecular Diagnostics Technology Consumption Value Comparison
  4.2.1 United States VS China: POCT Molecular Diagnostics Technology Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: POCT Molecular Diagnostics Technology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based POCT Molecular Diagnostics Technology Companies and Market Share, 2018-2023
  4.3.1 United States Based POCT Molecular Diagnostics Technology Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies POCT Molecular Diagnostics Technology Revenue, (2018-2023)
4.4 China Based Companies POCT Molecular Diagnostics Technology Revenue and Market Share, 2018-2023
  4.4.1 China Based POCT Molecular Diagnostics Technology Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies POCT Molecular Diagnostics Technology Revenue, (2018-2023)
4.5 Rest of World Based POCT Molecular Diagnostics Technology Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based POCT Molecular Diagnostics Technology Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies POCT Molecular Diagnostics Technology Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World POCT Molecular Diagnostics Technology Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Molecular Point-of-Care Diagnostics
  5.2.2 Near-Patient Molecular
5.3 Market Segment by Type
  5.3.1 World POCT Molecular Diagnostics Technology Market Size by Type (2018-2023)
  5.3.2 World POCT Molecular Diagnostics Technology Market Size by Type (2024-2029)
  5.3.3 World POCT Molecular Diagnostics Technology Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World POCT Molecular Diagnostics Technology Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Microbiology Laboratory
  6.2.2 Hospital
  6.2.3 Clinic
6.3 Market Segment by Application
  6.3.1 World POCT Molecular Diagnostics Technology Market Size by Application (2018-2023)
  6.3.2 World POCT Molecular Diagnostics Technology Market Size by Application (2024-2029)
  6.3.3 World POCT Molecular Diagnostics Technology Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Ustar Biotechnologies (Hangzhou) Ltd.
  7.1.1 Ustar Biotechnologies (Hangzhou) Ltd. Details
  7.1.2 Ustar Biotechnologies (Hangzhou) Ltd. Major Business
  7.1.3 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Technology Product and Services
  7.1.4 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Ustar Biotechnologies (Hangzhou) Ltd. Recent Developments/Updates
  7.1.6 Ustar Biotechnologies (Hangzhou) Ltd. Competitive Strengths & Weaknesses
7.2 Cepheid
  7.2.1 Cepheid Details
  7.2.2 Cepheid Major Business
  7.2.3 Cepheid POCT Molecular Diagnostics Technology Product and Services
  7.2.4 Cepheid POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Cepheid Recent Developments/Updates
  7.2.6 Cepheid Competitive Strengths & Weaknesses
7.3 Abbott Laboratories
  7.3.1 Abbott Laboratories Details
  7.3.2 Abbott Laboratories Major Business
  7.3.3 Abbott Laboratories POCT Molecular Diagnostics Technology Product and Services
  7.3.4 Abbott Laboratories POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Abbott Laboratories Recent Developments/Updates
  7.3.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.4 Roche Holding AG
  7.4.1 Roche Holding AG Details
  7.4.2 Roche Holding AG Major Business
  7.4.3 Roche Holding AG POCT Molecular Diagnostics Technology Product and Services
  7.4.4 Roche Holding AG POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Roche Holding AG Recent Developments/Updates
  7.4.6 Roche Holding AG Competitive Strengths & Weaknesses
7.5 BioFire Diagnostics
  7.5.1 BioFire Diagnostics Details
  7.5.2 BioFire Diagnostics Major Business
  7.5.3 BioFire Diagnostics POCT Molecular Diagnostics Technology Product and Services
  7.5.4 BioFire Diagnostics POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 BioFire Diagnostics Recent Developments/Updates
  7.5.6 BioFire Diagnostics Competitive Strengths & Weaknesses
7.6 Beijing Bohui Innovat Biotech Grp Co Ltd.
  7.6.1 Beijing Bohui Innovat Biotech Grp Co Ltd. Details
  7.6.2 Beijing Bohui Innovat Biotech Grp Co Ltd. Major Business
  7.6.3 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Technology Product and Services
  7.6.4 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Beijing Bohui Innovat Biotech Grp Co Ltd. Recent Developments/Updates
  7.6.6 Beijing Bohui Innovat Biotech Grp Co Ltd. Competitive Strengths & Weaknesses
7.7 CapitalBio Corporation
  7.7.1 CapitalBio Corporation Details
  7.7.2 CapitalBio Corporation Major Business
  7.7.3 CapitalBio Corporation POCT Molecular Diagnostics Technology Product and Services
  7.7.4 CapitalBio Corporation POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 CapitalBio Corporation Recent Developments/Updates
  7.7.6 CapitalBio Corporation Competitive Strengths & Weaknesses
7.8 Daan Gene
  7.8.1 Daan Gene Details
  7.8.2 Daan Gene Major Business
  7.8.3 Daan Gene POCT Molecular Diagnostics Technology Product and Services
  7.8.4 Daan Gene POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Daan Gene Recent Developments/Updates
  7.8.6 Daan Gene Competitive Strengths & Weaknesses
7.9 Sansure Biotech
  7.9.1 Sansure Biotech Details
  7.9.2 Sansure Biotech Major Business
  7.9.3 Sansure Biotech POCT Molecular Diagnostics Technology Product and Services
  7.9.4 Sansure Biotech POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Sansure Biotech Recent Developments/Updates
  7.9.6 Sansure Biotech Competitive Strengths & Weaknesses
7.10 Coyote Bioscience Co., Ltd.
  7.10.1 Coyote Bioscience Co., Ltd. Details
  7.10.2 Coyote Bioscience Co., Ltd. Major Business
  7.10.3 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Technology Product and Services
  7.10.4 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Coyote Bioscience Co., Ltd. Recent Developments/Updates
  7.10.6 Coyote Bioscience Co., Ltd. Competitive Strengths & Weaknesses
7.11 Genmark Diagnostics, Inc.
  7.11.1 Genmark Diagnostics, Inc. Details
  7.11.2 Genmark Diagnostics, Inc. Major Business
  7.11.3 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Technology Product and Services
  7.11.4 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Genmark Diagnostics, Inc. Recent Developments/Updates
  7.11.6 Genmark Diagnostics, Inc. Competitive Strengths & Weaknesses
7.12 Mobidiag
  7.12.1 Mobidiag Details
  7.12.2 Mobidiag Major Business
  7.12.3 Mobidiag POCT Molecular Diagnostics Technology Product and Services
  7.12.4 Mobidiag POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Mobidiag Recent Developments/Updates
  7.12.6 Mobidiag Competitive Strengths & Weaknesses
7.13 Wondfo
  7.13.1 Wondfo Details
  7.13.2 Wondfo Major Business
  7.13.3 Wondfo POCT Molecular Diagnostics Technology Product and Services
  7.13.4 Wondfo POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Wondfo Recent Developments/Updates
  7.13.6 Wondfo Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 POCT Molecular Diagnostics Technology Industry Chain
8.2 POCT Molecular Diagnostics Technology Upstream Analysis
8.3 POCT Molecular Diagnostics Technology Midstream Analysis
8.4 POCT Molecular Diagnostics Technology Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World POCT Molecular Diagnostics Technology Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World POCT Molecular Diagnostics Technology Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World POCT Molecular Diagnostics Technology Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World POCT Molecular Diagnostics Technology Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World POCT Molecular Diagnostics Technology Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World POCT Molecular Diagnostics Technology Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World POCT Molecular Diagnostics Technology Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World POCT Molecular Diagnostics Technology Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World POCT Molecular Diagnostics Technology Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key POCT Molecular Diagnostics Technology Players in 2022
Table 12. World POCT Molecular Diagnostics Technology Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global POCT Molecular Diagnostics Technology Company Evaluation Quadrant
Table 14. Head Office of Key POCT Molecular Diagnostics Technology Player
Table 15. POCT Molecular Diagnostics Technology Market: Company Product Type Footprint
Table 16. POCT Molecular Diagnostics Technology Market: Company Product Application Footprint
Table 17. POCT Molecular Diagnostics Technology Mergers & Acquisitions Activity
Table 18. United States VS China POCT Molecular Diagnostics Technology Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China POCT Molecular Diagnostics Technology Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based POCT Molecular Diagnostics Technology Companies, Headquarters (States, Country)
Table 21. United States Based Companies POCT Molecular Diagnostics Technology Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies POCT Molecular Diagnostics Technology Revenue Market Share (2018-2023)
Table 23. China Based POCT Molecular Diagnostics Technology Companies, Headquarters (Province, Country)
Table 24. China Based Companies POCT Molecular Diagnostics Technology Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies POCT Molecular Diagnostics Technology Revenue Market Share (2018-2023)
Table 26. Rest of World Based POCT Molecular Diagnostics Technology Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies POCT Molecular Diagnostics Technology Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies POCT Molecular Diagnostics Technology Revenue Market Share (2018-2023)
Table 29. World POCT Molecular Diagnostics Technology Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World POCT Molecular Diagnostics Technology Market Size by Type (2018-2023) & (USD Million)
Table 31. World POCT Molecular Diagnostics Technology Market Size by Type (2024-2029) & (USD Million)
Table 32. World POCT Molecular Diagnostics Technology Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World POCT Molecular Diagnostics Technology Market Size by Application (2018-2023) & (USD Million)
Table 34. World POCT Molecular Diagnostics Technology Market Size by Application (2024-2029) & (USD Million)
Table 35. Ustar Biotechnologies (Hangzhou) Ltd. Basic Information, Area Served and Competitors
Table 36. Ustar Biotechnologies (Hangzhou) Ltd. Major Business
Table 37. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Technology Product and Services
Table 38. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Ustar Biotechnologies (Hangzhou) Ltd. Recent Developments/Updates
Table 40. Ustar Biotechnologies (Hangzhou) Ltd. Competitive Strengths & Weaknesses
Table 41. Cepheid Basic Information, Area Served and Competitors
Table 42. Cepheid Major Business
Table 43. Cepheid POCT Molecular Diagnostics Technology Product and Services
Table 44. Cepheid POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Cepheid Recent Developments/Updates
Table 46. Cepheid Competitive Strengths & Weaknesses
Table 47. Abbott Laboratories Basic Information, Area Served and Competitors
Table 48. Abbott Laboratories Major Business
Table 49. Abbott Laboratories POCT Molecular Diagnostics Technology Product and Services
Table 50. Abbott Laboratories POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Abbott Laboratories Recent Developments/Updates
Table 52. Abbott Laboratories Competitive Strengths & Weaknesses
Table 53. Roche Holding AG Basic Information, Area Served and Competitors
Table 54. Roche Holding AG Major Business
Table 55. Roche Holding AG POCT Molecular Diagnostics Technology Product and Services
Table 56. Roche Holding AG POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Holding AG Recent Developments/Updates
Table 58. Roche Holding AG Competitive Strengths & Weaknesses
Table 59. BioFire Diagnostics Basic Information, Area Served and Competitors
Table 60. BioFire Diagnostics Major Business
Table 61. BioFire Diagnostics POCT Molecular Diagnostics Technology Product and Services
Table 62. BioFire Diagnostics POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BioFire Diagnostics Recent Developments/Updates
Table 64. BioFire Diagnostics Competitive Strengths & Weaknesses
Table 65. Beijing Bohui Innovat Biotech Grp Co Ltd. Basic Information, Area Served and Competitors
Table 66. Beijing Bohui Innovat Biotech Grp Co Ltd. Major Business
Table 67. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Technology Product and Services
Table 68. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Beijing Bohui Innovat Biotech Grp Co Ltd. Recent Developments/Updates
Table 70. Beijing Bohui Innovat Biotech Grp Co Ltd. Competitive Strengths & Weaknesses
Table 71. CapitalBio Corporation Basic Information, Area Served and Competitors
Table 72. CapitalBio Corporation Major Business
Table 73. CapitalBio Corporation POCT Molecular Diagnostics Technology Product and Services
Table 74. CapitalBio Corporation POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. CapitalBio Corporation Recent Developments/Updates
Table 76. CapitalBio Corporation Competitive Strengths & Weaknesses
Table 77. Daan Gene Basic Information, Area Served and Competitors
Table 78. Daan Gene Major Business
Table 79. Daan Gene POCT Molecular Diagnostics Technology Product and Services
Table 80. Daan Gene POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Daan Gene Recent Developments/Updates
Table 82. Daan Gene Competitive Strengths & Weaknesses
Table 83. Sansure Biotech Basic Information, Area Served and Competitors
Table 84. Sansure Biotech Major Business
Table 85. Sansure Biotech POCT Molecular Diagnostics Technology Product and Services
Table 86. Sansure Biotech POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sansure Biotech Recent Developments/Updates
Table 88. Sansure Biotech Competitive Strengths & Weaknesses
Table 89. Coyote Bioscience Co., Ltd. Basic Information, Area Served and Competitors
Table 90. Coyote Bioscience Co., Ltd. Major Business
Table 91. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Technology Product and Services
Table 92. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Coyote Bioscience Co., Ltd. Recent Developments/Updates
Table 94. Coyote Bioscience Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Genmark Diagnostics, Inc. Basic Information, Area Served and Competitors
Table 96. Genmark Diagnostics, Inc. Major Business
Table 97. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Technology Product and Services
Table 98. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Genmark Diagnostics, Inc. Recent Developments/Updates
Table 100. Genmark Diagnostics, Inc. Competitive Strengths & Weaknesses
Table 101. Mobidiag Basic Information, Area Served and Competitors
Table 102. Mobidiag Major Business
Table 103. Mobidiag POCT Molecular Diagnostics Technology Product and Services
Table 104. Mobidiag POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Mobidiag Recent Developments/Updates
Table 106. Wondfo Basic Information, Area Served and Competitors
Table 107. Wondfo Major Business
Table 108. Wondfo POCT Molecular Diagnostics Technology Product and Services
Table 109. Wondfo POCT Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of POCT Molecular Diagnostics Technology Upstream (Raw Materials)
Table 111. POCT Molecular Diagnostics Technology Typical Customers

LIST OF FIGURES

Figure 1. POCT Molecular Diagnostics Technology Picture
Figure 2. World POCT Molecular Diagnostics Technology Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World POCT Molecular Diagnostics Technology Total Market Size (2018-2029) & (USD Million)
Figure 4. World POCT Molecular Diagnostics Technology Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World POCT Molecular Diagnostics Technology Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company POCT Molecular Diagnostics Technology Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company POCT Molecular Diagnostics Technology Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company POCT Molecular Diagnostics Technology Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company POCT Molecular Diagnostics Technology Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company POCT Molecular Diagnostics Technology Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company POCT Molecular Diagnostics Technology Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company POCT Molecular Diagnostics Technology Revenue (2018-2029) & (USD Million)
Figure 13. POCT Molecular Diagnostics Technology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 16. World POCT Molecular Diagnostics Technology Consumption Value Market Share by Region (2018-2029)
Figure 17. United States POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 18. China POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 23. India POCT Molecular Diagnostics Technology Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of POCT Molecular Diagnostics Technology by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for POCT Molecular Diagnostics Technology Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for POCT Molecular Diagnostics Technology Markets in 2022
Figure 27. United States VS China: POCT Molecular Diagnostics Technology Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: POCT Molecular Diagnostics Technology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World POCT Molecular Diagnostics Technology Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World POCT Molecular Diagnostics Technology Market Size Market Share by Type in 2022
Figure 31. Molecular Point-of-Care Diagnostics
Figure 32. Near-Patient Molecular
Figure 33. World POCT Molecular Diagnostics Technology Market Size Market Share by Type (2018-2029)
Figure 34. World POCT Molecular Diagnostics Technology Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World POCT Molecular Diagnostics Technology Market Size Market Share by Application in 2022
Figure 36. Microbiology Laboratory
Figure 37. Hospital
Figure 38. Clinic
Figure 39. POCT Molecular Diagnostics Technology Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source


More Publications